EPSTEIN-BARR VIRUS ASSOCIATED BURKITT LYMPHOMA IN A HEART TRANSPLANT RECIPIENT1
- 1 September 1996
- journal article
- case report
- Published by Wolters Kluwer Health in Transplantation
- Vol. 62 (6), 869-872
- https://doi.org/10.1097/00007890-199609270-00030
Abstract
This report describes a case of Epstein Barr Virus related post-transplantation B lymphoproliferative disease of unusual Burkitt lymphoma(BL) type in which combined cytotoxic agents (PACE BOM) successfully produced complete and long-term tumor remission.Keywords
This publication has 6 references indexed in Scilit:
- Intensive weekly combination chemotherapy for patients with intermediate-grade and high-grade non-Hodgkin's lymphoma.Journal of Clinical Oncology, 1991
- Gene rearrangement in B- and T-lymphoproliferative disease detected by the polymerase chain reaction [see comments]Blood, 1991
- Epstein-Barr Virus-Associated Lymphoproliferative Disorders in Immunocompromised IndividualsAdvances in Cancer Research, 1991
- IMMUNOHISTOLOGY OF EPSTEIN-BARR VIRUS-ASSOCIATED ANTIGENS IN B CELL DISORDERS FROM IMMUNOCOMPROMISED INDIVIDUALSTransplantation, 1990
- Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance.The Journal of Experimental Medicine, 1988
- Restricted expression of EBV latent genes and T-lymphocyte-detected membrane antigen in Burkitt's lymphoma cells.The EMBO Journal, 1986